AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines
HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company's research and development of a diploid rabies vaccine has recently received the...
China's First Factory-Based Seawater Hydrogen Production Project Completed at Sinopec Qingdao Refinery
QINGDAO, China, Dec. 19, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation's (HKG: 0386, "Sinopec") completes China's first factory-based seawater hydrogen production research project at its Qingdao Refinery. The project integrates...